Ono Pharmaceutical Co. Ltd. Registered Shares o.N.Ono Pharmaceutical Co. Ltd. Registered Shares o.N.Ono Pharmaceutical Co. Ltd. Registered Shares o.N.

Ono Pharmaceutical Co. Ltd. Registered Shares o.N.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.25 B‬EUR
1.258EUR
‪783.64 M‬EUR
‪3.08 B‬EUR
‪328.04 M‬
Beta (1Y)
0.41
Employees (FY)
‪3.85 K‬
Change (1Y)
+92 +2.45%
Revenue / Employee (1Y)
‪861.97 K‬EUR
Net income / Employee (1Y)
‪219.45 K‬EUR

About ONO PHARMACEUTICAL CO


CEO
Gyo Sagara
Headquarters
Osaka
Website
Founded
1947
ISIN
JP3197600004
FIGI
BBG000C4Q9Y2
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ON4 is 10.700 EUR — it has decreased by −3.60% in the past 24 hours. Watch Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stocks are traded under the ticker ON4.
ON4 stock has fallen by −9.32% compared to the previous week, the month change is a −10.08% fall, over the last year Ono Pharmaceutical Co. Ltd. Registered Shares o.N. has showed a −32.28% decrease.
We've gathered analysts' opinions on Ono Pharmaceutical Co. Ltd. Registered Shares o.N. future price: according to them, ON4 price has a max estimate of 15.19 EUR and a min estimate of 10.33 EUR. Watch ON4 chart and read a more detailed Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock forecast: see what analysts think of Ono Pharmaceutical Co. Ltd. Registered Shares o.N. and suggest that you do with its stocks.
ON4 reached its all-time high on Jul 14, 2022 with the price of 27.600 EUR, and its all-time low was 11.300 EUR and was reached on Oct 25, 2024. View more price dynamics on ON4 chart.
See other stocks reaching their highest and lowest prices.
ON4 stock is 0.00% volatile and has beta coefficient of 0.41. Track Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock price on the chart and check out the list of the most volatile stocks — is Ono Pharmaceutical Co. Ltd. Registered Shares o.N. there?
Today Ono Pharmaceutical Co. Ltd. Registered Shares o.N. has the market capitalization of ‪5.24 B‬, it has decreased by −3.44% over the last week.
Yes, you can track Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financials in yearly and quarterly reports right on TradingView.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.30 EUR per share, whereas the estimation was 0.32 EUR resulting in a −5.97% surprise. The estimated earnings for the next quarter are 0.25 EUR per share. See more details about Ono Pharmaceutical Co. Ltd. Registered Shares o.N. earnings.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. revenue for the last quarter amounts to ‪766.45 M‬ EUR, despite the estimated figure of ‪789.55 M‬ EUR. In the next quarter, revenue is expected to reach ‪795.91 M‬ EUR.
ON4 net income for the last quarter is ‪105.35 M‬ EUR, while the quarter before that showed ‪143.79 M‬ EUR of net income which accounts for −26.73% change. Track more Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financial stats to get the full picture.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 15, 2024, the company has ‪3.85 K‬ employees. See our rating of the largest employees — is Ono Pharmaceutical Co. Ltd. Registered Shares o.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ono Pharmaceutical Co. Ltd. Registered Shares o.N. EBITDA is ‪877.30 M‬ EUR, and current EBITDA margin is 36.15%. See more stats in Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financial statements.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ono Pharmaceutical Co. Ltd. Registered Shares o.N. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock shows the strong sell signal. See more of Ono Pharmaceutical Co. Ltd. Registered Shares o.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.